Documente Academic
Documente Profesional
Documente Cultură
Utilizari terapeutice
In Romania, pe piata farmaceutica, isoprinosina se prezinta sub forma de
comprimate albe, ca substanta activa cu indicatii in infectii respiratorii virale,
gripa, herpes sau ulceratii ale mucoasei bucale (produse de herpes simplex), herpes
genital, herpes Zoster, varicela severa sau complicata, rubeola severa sau
complicata, hepatita virala acuta, hepatita B cronica activa, panencefalita
sclerozanta subacuta (PESS), pre-SIDA, papiloame virale, rezistenta imunologica
scazuta, ca terapie adjuvanta. Este indicata administrarea a doua comprimate
isoprinosina de 3 ori pe zi pentru adulti si varstnici si 50 mg/kg pe zi la copii. In
cazul acestora din urma, comprimatul poate fi zdrobit si dizolvat intr-un lichid, de
exemplu lapte sau suc de fructe. Tratamentul dureaza pe tot parcursul afectiunii si
inca 3 zile de la disparitia simptomelor.
Pentru infectii recurente trebuie urmat un tratament complet continuand 1-2 zile
dupa ameliorarea simptomelor. Ulterior, trebuie continuata utilizarea isoprinosinei
in doza redusa de intretinere: 1-2 comprimate pe zi (pentru copii, jumatate din doza
adultului), pana la instalarea primelor semne de recurenta. Apoi se va administra
doza intreaga initiala inca 1-2 zile de la ameliorarea simptomelor.
In caz de infectii cronice, doza de 50 mg/kg pe zi se administreaza dupa cum
urmeaza: cazuri asimptomatice 30 zile de tratament, 60 zile de pauza; simptome
usoare 60 zile de tratament, 30 zile de pauza; simptome severe 90 zile de
tratament, 30 zile de pauza. Aceste doze pot fi repetate daca medicul considera
necesar, sub supravegherea stricta a acestuia.
Ca si alte medicamente, isoprinosina poate avea reactii adverse, de obicei rare si
tranzitorii. Cea mai frecventa reactie adversa este cresterea concentratiei de acid
uric din plasma si urina, reversibile la sfarsitul tratamentului. Mai pot aparea greata
cu sau fara varsaturi, disconfort epigastric, cresterea valorilor transaminazelor,
fosfatazei alcaline sau azotului ureic din sange, prurit, eruptii cutanate, cefalee,
vertij, oboseala, indispozitie, artralgii.
Bibliografie:
Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI (2002). Inosine induces
axonal rewiring and improves behavioral outcome after stroke. Proc. Natl. Acad.
Sci. U.S.A. 99 (13): 90316..
Treatment of Multiple Sclerosis Using Over the Counter Inosine Full Text
View - ClinicalTrials.gov
Uric Acid: Natural Scavenger Of Peroxynitrite. Alseres pharma drug description.
ATC/DDD Index. http://www.whocc.no/atc_ddd_index/?code=D06BB05.
www.pharmabook.net
www.medhelp.org
http://www.tiopoietine.info/Molixengl.htm
Petrova M, Jelev D, Ivanova A, Krastev Z., Isoprinosine affects serum cytokine
levels in healthy adults, J Interferon Cytokine Res. 2010 Apr;30(4):223-8
Femiano F, Gombos F, Scully C.Oral proliferative verrucous leukoplakia (PVL);
open trial of surgery compared with combined therapy using surgery and
methisoprinol in papillomavirus-related PVL, int J Oral Maxillofac Surg. 2001
Aug
Campbell C, Levin S, Humphreys P, Walop W, Brannan R. Subacute sclerosing
panencephalitis: results of the Canadian Paediatric Surveillance Program and
review of the literature. BMC Pediatr. 2005 Dec 15
Aydin OF, Senbil N, Kuyucu N, Grer YK. Combined treatment with
subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute
sclerosing panencephalitis.Child Neurol. 2003 Feb;18(2):104-8.
Oral inosiplex in the treatment of cervical condylomata acuminata: a randomised
placebo-controlled trial.Georgala S, Katoulis AC, Befon A, Georgala C,
Rigopoulos D., 2007 Apr;114(4):509;
Acta Derm Venereol. 2006;86(5):422-4. Inosiplex for treatment of alopecia areata:
a randomized placebo-controlled study.Georgala S, Katoulis AC, Befon A,
Georgala K, Stavropoulos PG.t
Inosine reduces inflammation and improvesis survival in a murine model of colit J.
G. Mabley1, P. Pacher1, L. Liaudet2, F. G. Soriano2, G. Hasko2, A. Marton1, C.
Szabo1,2, and A. L. Salzman, Vol. 284, Issue 1, G138-G144, January 2003
Am. J. Respir. Crit. Care Med., Volume 164, Number 7, October 2001, 12131220. Inosine Reduces Systemic Inflammation and Improves Survival in Septic
Shock Induced by Cecal Ligation and Puncture. Lucas Liaudet, Jon G. Mabley,
Francisco Garcia Soriano, Pal Pacher, Anita Marton, Gyorgy Hasco, Csaba Szabo.
16.Int J Oral Maxillofac Surg. 2001 Aug;30(4):318-22. Oral proliferative
verrucous leukoplakia (PVL); open trial of surgery
compared with combined